Astrazeneca (AZN) Revenue (2009 - 2026)
Astrazeneca (AZN) reported Revenue of $15.07 billion for Q3 2026, up 4.9% from $14.37 billion a year earlier but down 2.1% from the prior quarter.
Astrazeneca (AZN) Revenue (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Astrazeneca's Revenue came in at $59.37 billion, up 7.8% year-over-year; for FY2025, it came in at $58.74 billion, up 8.6% from FY2024.
- Revenue has increased for seven consecutive years, with a five-year compound annual growth rate of 17.2% (FY2020 to FY2025).
- By year, Revenue came in at $54.07 billion in FY2024 (+18.0%), $45.81 billion in FY2023 (+3.3%), $44.35 billion in FY2022 (+18.5%) and $37.42 billion in FY2021 (+40.6%).
- Five-year quarterly Revenue spans a low of $10.57 billion in Q1 2023 and a high of $15.38 billion in Q2 2026.
- Year over year, Revenue has now increased in each of the last 14 quarters, with growth averaging 9.8% over the last eight quarters.
- The high point for year-over-year Revenue in five years was Q4 2021 (growth of 64.0%); the low point was Q1 2023 (a decline of 7.2%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $15.38 billion (Q2 2026), $14.39 billion (Q1 2026) and $14.54 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 212,806.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 24.40 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 25.40 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 17.40 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 18.09 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Astrazeneca | 46.55 Bn | 20.20 Bn | 13.26 Bn | 15.07 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 15.07 Bn |
| Jun 30, 2026 | 15.38 Bn |
| Mar 31, 2026 | 14.39 Bn |
| Dec 31, 2025 | 14.54 Bn |
| Sep 30, 2025 | 14.37 Bn |
| Jun 30, 2025 | 14.46 Bn |
| Mar 31, 2025 | 12.88 Bn |
| Dec 31, 2024 | 13.36 Bn |
| Sep 30, 2024 | 12.95 Bn |
| Jun 30, 2024 | 12.94 Bn |
| Mar 31, 2024 | 12.18 Bn |
| Dec 31, 2023 | 11.32 Bn |
| Sep 30, 2023 | 11.02 Bn |
| Jun 30, 2023 | 11.42 Bn |
| Mar 31, 2023 | 10.57 Bn |
| Dec 31, 2022 | 11.21 Bn |
| Sep 30, 2022 | 10.98 Bn |
| Jun 30, 2022 | 10.77 Bn |
| Mar 31, 2022 | 11.39 Bn |
| Dec 31, 2021 | 11.50 Bn |
Astrazeneca Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=AZN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();